Economic Evaluation of a Web Application Implemented in Primary Care for the Treatment of Depression in Patients With Type 2 Diabetes Mellitus: Multicenter Randomized Controlled Trial.

BACKGROUND: Depressive disorder and type 2 diabetes mellitus (T2DM) are prevalent in primary care (PC). Pharmacological treatment, despite controversy, is commonly chosen due to resource limitations and difficulties in accessing face-to-face interventions. Depression significantly impacts various aspects of a person's life, affecting adherence to medical prescriptions and glycemic control and leading to future complications and increased health care costs. To address these challenges, information and communication technologies (eg, eHealth) have been introduced, showing promise in improving treatment continuity and accessibility. However, while eHealth programs have demonstrated effectiveness in alleviating depressive symptoms, evidence regarding glycemic control remains inconclusive. This randomized controlled trial aimed to test the efficacy of a low-intensity psychological intervention via a web app for mild-moderate depressive symptoms in individuals with T2DM compared with treatment as usual (TAU) in PC. OBJECTIVE: This study aimed to analyze the cost-effectiveness and cost-utility of a web-based psychological intervention to treat depressive symptomatology in people with T2DM compared with TAU in a PC setting. METHODS: A multicenter randomized controlled trial was conducted with 49 patients with T2DM, depressive symptoms of moderate severity, and glycosylated hemoglobin (HbA1c) of 7.47% in PC settings. Patients were randomized to TAU (n=27) or a web-based psychological treatment group (n=22). This web-based treatment consisted of cognitive behavioral therapy, improvement of diabetes self-care behaviors, and mindfulness. Cost-effectiveness analysis for the improvement of depressive symptomatology was conducted based on reductions in 3, 5, or 50 points on the Patient Health Questionnaire-9 (PHQ-9). The efficacy of diabetes control was estimated based on a 0.5% reduction in HbA1c levels. Follow-up was performed at 3 and 6 months. The cost-utility analysis was performed based on quality-adjusted life years. RESULTS: Efficacy analysis showed that the web-based treatment program was more effective in improving depressive symptoms than TAU but showed only a slight improvement in HbA1c. Incremental cost-effectiveness ratios of 186.76 for a 3-point reduction in PHQ-9 and 206.31 for reductions of 5 and 50 percentage points were obtained. In contrast, the incremental cost-effectiveness ratio for improving HbA1c levels amounted to €1510.90 (€1=US $1.18 in 2018) per participant. The incremental cost-utility ratio resulted in €4119.33 per quality-adjusted life year gained. CONCLUSIONS: The intervention, using web-based modules incorporating cognitive behavioral therapy tools, diabetes self-care promotion, and mindfulness, effectively reduced depressive symptoms and enhanced glycemic control in patients with T2DM. Notably, it demonstrated clinical efficacy and economic efficiency. This supports the idea that eHealth interventions not only benefit patients clinically but also offer cost-effectiveness for health care systems. The study emphasizes the importance of including specific modules to enhance diabetes self-care behaviors in future web-based psychological interventions, emphasizing personalization and adaptation for this population. TRIAL REGISTRATION: ClinicalTrials.gov NCT03426709; https://clinicaltrials.gov/study/NCT03426709. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/S12888-019-2037-3.

Roles and competencies of the clinical psychologist in adult diabetes care-A consensus report.

AIMS: Psychological care is recognised as an integral part of quality diabetes care. We set out to describe the roles and competencies of the clinical psychologist as a member of the multidisciplinary adult diabetes care team, focused on secondary care. METHODS: The authors are clinically experienced psychologists involved in adult diabetes care, from Australia, Europe and North America, and active members of the international psychosocial aspects of diabetes study group. Consensus was reached as a group on the roles and competencies of the clinical psychologist working in adult diabetes secondary care, building both on expert opinion and a selective review and discussion of the literature on psychological care in diabetes, clinical guidelines and competency frameworks. RESULTS: The clinical psychologist fulfils multiple roles: (1) as a clinician (psychological assessment and therapy), (2) as advisor to the healthcare team (training, consulting), (3) as a communicator and promotor of person-centred care initiatives and (4) as a researcher. Four competencies that are key to successfully fulfilling the above-mentioned roles in a diabetes setting are as follows: (a) specialised knowledge, (b) teamwork and advice, (c) assessment, (d) psychotherapy (referred to as STAP framework). CONCLUSIONS: The roles and competencies of clinical psychologists working in diabetes extend beyond the requirements of most university and post-graduate curricula. There is a need for a comprehensive, accredited specialist post-graduate training for clinical psychologists working in diabetes care, building on the proposed STAP framework. This calls for a collaborative effort involving diabetes organisations, clinical psychology societies and diabetes psychology interest groups.

Precisión del diagnóstico de depresión en pacientes con diabetes mellitus tipo 1 / Accuracy of diagnosis of depression in patients with Type 1 diabetes mellitus

Este estudio valora la precisión que tiene el clínico (Médico Especialista en Endocrinología y Nutrición: MEEN) al realizar el diagnóstico de depresión en pacientes con diabetes mellitus tipo 1 (DM1). Participaron 11 MEEN y 153 pacientes con DM1. El diagnóstico de depresión se realizó mediante la entrevista estructurada SCID-1 y la valoración del clínico. De la muestra inicial se seleccionaron aleatoriamente 50 pacientes (imponiendo la condición de que estuviera compuesta por 25 pacientes con depresión y 25 sin depresión). Los resultados muestran que los clínicos realizaron un mayor porcentaje de diagnósticos negativos (paciente sin depresión) que positivos (paciente con depresión). Un porcentaje considerable de pacientes con depresión no fueron diagnosticados (25%). Parece, pues, necesario dotar a los clínicos de protocolos adecuados para evaluar la presencia de este trastorno en DM1, así como continuar la investigación sobre el proceso diagnóstico para la toma de decisiones clínicas (AU)

This study assesses the clinical accuracy of physicians (Specialists in Endocrinology and Nutrition: SEN) to make the diagnosis of depression in patients with Type 1 diabetes mellitus (DM1). This study involved 11 SEN physicians, and 153 patients with DM1. The diagnosis of depression was performed using the SCID-1 structured interview and clinical assessment. From the initial sample, 50 patients were randomly selected (imposing the condition that it was included 25 patients with depression and 25 without depression). The results show that clinicians performed a higher percentage of negative diagnoses (patients without depression) than positive ones (patients with depression). A significant percentage of patients with depression were not diagnosed (25%). It therefore seems necessary to provide adequate clinical protocols to evaluate the presence of this disorder in DM1, as well as continuing research into the diagnostic process for clinical decision making (AU)

Ansiedad, Depresión y otras variables en pacientes con diabetes mellitus Tipo I / Anxiety, depression and other variables in patients with type 1 diabetes mellitus

En el presente artículo se estudia si algunas variables psicológicas, biomédicas y sociodemográficas pueden predecir la calidad de vida de pacientes con diabetes mellitus tipo 1 (DM1) en tratamiento con Infusión Subcutánea Continua de Insulina (ISCI). Participaron 33 pacientes con DM1 que completaron una batería de test psicológicos (DQOL, BDI, STAI y MHLC). Hemos encontrado que la ansiedad, el sexo y las complicaciones de la enfermedad son variables importantes que permiten explicar su calidad de vida. Aunque no han alcanzado significación estadística en ninguno de los modelos, no deben desconsiderarse los datos obtenidos en otras variables como el control glucémico, locus de control interno o la depresión. Los resultados del estudio sugieren importantes implicaciones para el tratamiento integral de estos pacientes (AU)

The aim of this study is to analyse whether certain psychological, biomedical and socio demographic variables can predict the quality of life of patient with type 1 diabetes mellitus teasted with Continuous Subcutaneous Insulin Infusion (CSII). Thirty three patients with DM1 completed a battery of psychological tests (DQOL, BDI, STAI and MHLC). Results indicate that anxiety, sex and complications are important variables that can explain the quality of life. Although glycemic control, locus of internal control or depression have not reached statistical significance in any of the models, they should not be rejected. These results suggest important implications for the integral treatment of these patients (AU)

Predictores de Calidad de Vida en Pacientes con Diabetes Mellitus Tipo 1 / Predictors of Quality of Life in Patients with Type 1 Diabetes Mellitus

Resumen. En el presente artículo se pretende estudiar si variables psicológicas (depresión, ansiedad-estado, ansiedad-rasgo y locus de control) y metabólicas (control glucémico e hipoglucemias graves) pueden predecir la calidad de vida de pacientes con diabetes mellitus tipo 1 (DM1). Treinta y tres pacientes con DM1 completaron una batería de tests psicológicos (DQOL, BDI, STAI y MHLC). Los resultados muestran que la depresión y la ansiedad- rasgo son buenos predictores de la calidad de vida de los pacientes con DM1. El resto de las variables (locus de control, hemoglobina glicosilada e hipoglucemias graves) no se relacionan con la calidad de vida. Estos resultados evidencian que las variables psicológicas (depresión y ansiedad-rasgo) pueden ser buenos predictores de calidad de vida en pacientes con DM1. Por tanto, según nuestros resultados, para mejorar la calidad de vida de las personas con esta enfermedad habría que promover la aplicación de tratamientos psicológicos dirigidos a reducir su sintomatología depresiva y ansiosa (AU)

Abstract. The aim of this article is to study whether psychological (depression, state-anxiety, trait-anxiety and locus of control) and metabolic variables (glucemic control and serious hypoglycemic events) can predict the quality of life in patients with type 1 diabetes mellitus (DM1). Thirty-three patients with DM1 completed a battery of psychological tests (DQOL, BDI, STAI and MHLC). The results show that depression and trait-anxiety are good predictors of quality of life in DM1 patients. The rest of the variables (locus of control, glycosylated hemoglobin and serious hypoglycemic events) are not related to the quality of life. These results demonstrate that psychological variables (depression and trait-anxiety) can be good predictors of quality of life in DM1 patients. Therefore, according to our results, to improve the quality of life of people with this disease it would be necessary to promote the application of psychological treatments directed at reducing their depressive and anxious symptomatology (AU)

Creencias, afrontamiento y estado de ánimo deprimido en pacientescon dolor crónico / Beliefs, coping, and depressive mood state in chronic pain patients

En este estudio se analizan las posibles relaciones entre las creencias de dolor, las estrategias de afrontamiento (autoafirmaciones), el dolor percibido y el estado de ánimo deprimido en pacientes con dolor crónico. Se propone un modelo teórico que es contrastado en dos muestras de pacientes que acuden a diferentes servicios médicos para tratar su dolor, concretamente 100 pacientes de Reumatología y 114 de la Unidad del Dolor. Los resultados ponen de manifiesto la existencia de diferencias en cuanto a las relaciones entre las variables estudiadas en pacientes con dolor crónico de diferentes servicios médicos. Como conclusiones generales se destaca que las creencias mantenidas ponlos pacientes influyen sobre la percepción de su dolor, sin embargo, no se encuentran relaciones significativas entre el tipo de autoafirmaciones empleadas y dolor percibido. Finalmente, el dolor que el paciente percibe y el estado emocional deprimido correlacionan positivamente (AU)

This study analyses the relationship between pain-related beliefs, coping strategies (self-statements), pain perception, and depressive mood state in chronic pain patients. A theoretical model is proposed and tested with two groups of chronic patients attending two different medical services. The sample was made up of 100 patients from the Rheumatology Unit, and 114 patients from a Pain Clinic. The results suggest that there are differences in the relationships between the different variables studied. A general conclusion is that the pain-related beliefs of patients with chronic pain play a important role on pain perception. However, no significant relationships were found between self-statements and pain. Finally, the pain intensity and the depressed mood are positively correlated (AU)

Evaluación de la interacción profesional de la salud-paciente: validación preliminar de un cuestionario para padres de niños con diabetes mellitus insulino-dependiente / Health proffesional-patient interaction assessment: preliminary validation of a questionnaire for parents of children with insulin-dependent diabetes mellitus

Este trabajo presenta los resultados de un estudio preliminar relativos a la consistencia interna, estructura factorial y análisis de ítems del 'Cuestionario de Interacción Personal Sanitario-Padres de Niños con Diabetes' (C.I.PE.PA.N.DI), una prueba que evalúa la interacción percibida entre padres de niños diabéticos y los profesionales de salud. 153 padres, 88 madres y 65 padres, de niños con diabetes insulino-dependiente (DMID) completaron el cuestionario. Se halló la consistencia interna de la versión de 30 ítems (alpha de Cronbach=0,95) con correlaciones ítem-test altas. Los análisis resultaron en un factor principal que explicó el 40,99 por ciento de la varianza. Concluimos que se trata de un prometedor instrumento para evaluar la interacción entre los profesionales de salud y los padres de niños con DMID y proponemos futuros estudios para analizar otros índices de fiabilidad y validez (AU)

Adaptación al castellano de la escala Courtauld de control emocional en pacientes con cáncer / Spanish adaptation of the Courtauld Emotional Control Scale: evidence of a exploratory analysis in patients with cancer

Los estudios en torno al "Tipo C" constituyen un importante tópico de la investigación generando en los últimos treinta años más de 300 artículos y 68 libros y capítulos de libros (Fernández-Ballesteros y Ruis, 1997). Aunque el núcleo del "Tipo C" parece estar bien delimitado (inhibición, represión o supresión de las emociones negativas- o anti-emocionalidad- junto con la necesidad de mantener relaciones interpersonales armoniosas), no existe acuerdo entre la naturaleza de estas variables. Así mientras unos autores consideran que se trata de mecanismos de defensa frente a la ansiedad (Temoshock y Dreher, 1992; Spielberg, 1988a), otros sostienen que, más bien, puede ser considerado un estilo o patrón comportamental de anti-emocionalidad o supresión emocional (Greer y Watson, 1985). Más aún, dentro de este último grupo existen autores que plantean para este estilo comportamental una especificidad por emociones (Watson y Greer, 1983), frente a otros que defienden una especificidad por acciones (Bleiker, Van Der Ploeg, Hendriks, Leer y Kleijn, 1993). Los resultados son consistentes (aunque parcialmente) con ambas propuestas (AU)

In the last 30 years, the contribution of «Type C» to cancer disease has been an important research topic. From 1974 through 1995 a search of the literature on Psychlit and Medline identified more than 300 journal articles and 68 books and book chapters (Fernández-Ballesteros y Ruiz, 1997). Although the principal variables of «Type C» has been identified (inhibition, repression or suppression of negative emotions - anti-emotionality - and need for harmony), there is not agreement about the nature of this variables. Thus, for some authors the variables mentioned are defensiveness mechanisms to anxiety (Temoshok y Dreher, 1992; Spielberger, 1988a). Other authors consider the variables said as a behavioural style of anti-emotionality or suppression emotional (Greer y Watson, 1985). On the other hand, between this authors that defend that «Type C» is a behavioural style neither there is agreement. So, while Watson y Greer (1983) emphasize specific «Type C» components related to the emotions (anger, anxiety, depressed mood - only control - ), Bleiker, Van Der Ploeg, Hendriks, Leer y Kleijn (1993) emphasize specific «Type C» components related to the actions (expression, repression and emotional control). The results are consistent (only partially) with both proposal (AU)